MRCK34:BVMF
Merck BDR
R$ ९७.०४
०.००%
(०.००) 1D
सेप्टेम्बर ४, १७:०६:०० GMT-३ · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MRCK34...
Open
R$ ९६.५०
High
R$ ९७.०४
Low
R$ ९६.२०
Mkt. cap
३.७१ खरब
Avg. vol.
३.७३ हजार
Volume
५८.७८ हजार
52-wk high
R$ १०१.३८
52-wk low
R$ ५१.०६
Shares outstanding
२.४७ अरब
No. of employees
७४ हजार
Open
R$ ९६.५०
High
R$ ९७.०४
Low
R$ ९६.२०
Mkt. cap
३.७१ खरब
Avg. vol.
३.७३ हजार
Volume
५८.७८ हजार
52-wk high
R$ १०१.३८
52-wk low
R$ ५१.०६
Shares outstanding
२.४७ अरब
No. of employees
७४ हजार
News stories
From web sources and news partners
MarketBeat
·
१६ घण्टा पहिले
Merck & Co., Inc. $MRK Shares Bought by Saudi Central Bank
Trefis
·
३ दिन पहिले
Is Merck Stock Pricing In A Post-Keytruda Future Too Soon?
24/7 Wall St.
·
२ हप्ता पहिले
Eli Lilly, Novo Nordisk and Merck: Buy, Sell or Hold?
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck BDR